BioMarin Pharmaceutical Inc. - Strategy and SWOT Report
is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Detailed information on BioMarin Pharmaceutical Inc. required for business and competitor intelligence needs
A study of the major internal and external factors affecting BioMarin Pharmaceutical Inc. in the form of a SWOT analysis
An in-depth view of the business model of BioMarin Pharmaceutical Inc. including a breakdown and examination of key business segments
Intelligence on BioMarin Pharmaceutical Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about BioMarin Pharmaceutical Inc., such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
BioMarin Pharmaceutical (BioMarin or 'the company'), a commercial-stage biopharmaceutical company, develops and commercializes biopharmaceuticals for the treatment of serious diseases and medical conditions. The company operates in the US, Europe and Latin America. It is headquartered in San Rafael, California, and employed 1,341 people as of January 24, 2014. The company recorded revenues of $548.5 million during the financial year ended December 2013 (FY2013), an increase of 9.5% over FY2012. The operating loss of the company was $156 million in FY2013, as compared to an operating loss of $110.2 million in FY2012. The net loss of the company was $176.4 million in FY2013, as compared to a net loss of $114.3 million in FY2012.
Reasons to Purchase:
Gain understanding of BioMarin Pharmaceutical Inc. and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess BioMarin Pharmaceutical Inc. as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on BioMarin Pharmaceutical Inc.’s business structure, strategy and prospects